Coşkuner, T. Et Al. 2023. The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study. Expert Opinion on Biological Therapy , vol.23, no.12 , 1299-1306.

Coşkuner, T., Çağlayan, Ş., Akgün, Ö., TORUN, R., Yayla, E. N. S., Bagrul, İ., ... Kılbaş, G.(2023). The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study. Expert Opinion on Biological Therapy , vol.23, no.12, 1299-1306.

Coşkuner, Taner Et Al. "The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study," Expert Opinion on Biological Therapy , vol.23, no.12, 1299-1306, 2023

Coşkuner, Taner Et Al. "The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study." Expert Opinion on Biological Therapy , vol.23, no.12, pp.1299-1306, 2023

Coşkuner, T. Et Al. (2023) . "The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study." Expert Opinion on Biological Therapy , vol.23, no.12, pp.1299-1306.

@article{article, author={Taner Coşkuner Et Al. }, title={The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study}, journal={Expert Opinion on Biological Therapy}, year=2023, pages={1299-1306} }